Study probes whether common osteoporosis meds harm dental implants

NCT ID NCT07150351

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

Researchers at National Taiwan University Hospital reviewed records of 300 dental implant patients to see if those taking oral anti-resorptive drugs (used for bone conditions like osteoporosis) had different implant success rates. The study compared patients who took these medications with those who did not. This completed observational study aims to provide real-world insights for dentists and patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If the results show a clear link, dentists may better advise patients on implant risks when taking bone-strengthening medications.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. The findings may not apply to other populations or implant types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DENTAL IMPLANT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Taiwan University Hospital

    Taipei, Zhongzheng Dist., 100, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.